Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CEV With or Without Periocular Carboplatin for Nonmetastatic Extraocular Retinoblastoma
NCT02319486Phase 4Completed
- Sponsor
- Sun Yat-sen University
- Start
- Jan 2009
- Primary completion
- Apr 2014
- Modality
- DNA Intercalators/Alkylators
01
Overview
A Phase 4 trial of carboplatin in retinoblastoma (Rb), sponsored by Sun Yat-sen University. Started Jan 2009; status: completed.
02
Drugs
carboplatin
03
Conditions
retinoblastoma (Rb)
Beyond the preview
Go deeper on NCT02319486.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02319486.